Novel management strategies for idiopathic pulmonary fibrosis
K Ahmad, SD Nathan - Expert Review of Respiratory Medicine, 2018 - Taylor & Francis
Introduction: Idiopathic pulmonary fibrosis (IPF) treatment was revolutionized by the advent
of two novel antifibrotics, nintedanib and pirfenidone. However, neither is a panacea and …
of two novel antifibrotics, nintedanib and pirfenidone. However, neither is a panacea and …
[HTML][HTML] The management of patients with idiopathic pulmonary fibrosis
P Spagnolo, A Tzouvelekis, F Bonella - Frontiers in medicine, 2018 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF), the most common form of fibrosing idiopathic interstitial
pneumonia, is an inexorably progressive disease with a 5-year survival of~ 20%. In the last …
pneumonia, is an inexorably progressive disease with a 5-year survival of~ 20%. In the last …
Emerging therapeutic interventions for idiopathic pulmonary fibrosis
Introduction: Idiopathic pulmonary fibrosis (IPF) is a devastating and relentlessly progressive
lung disorder. Previously, it was thought to be a chronic inflammatory disease; however, it is …
lung disorder. Previously, it was thought to be a chronic inflammatory disease; however, it is …
[HTML][HTML] Novel approaches to pulmonary fibrosis
G Jenkins, A Goodwin - Clinical Medicine, 2014 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a poor prognosis and few
treatment options. However, recent research into this condition has led to considerable …
treatment options. However, recent research into this condition has led to considerable …
Pharmacological treatment of idiopathic pulmonary fibrosis: current approaches, unsolved issues, and future perspectives
M Kreuter, F Bonella, M Wijsenbeek… - BioMed research …, 2015 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5‐year survival of
approximately 20%. The disease primarily occurs in elderly patients. IPF is a highly …
approximately 20%. The disease primarily occurs in elderly patients. IPF is a highly …
The therapy of idiopathic pulmonary fibrosis: what is next?
V Somogyi, N Chaudhuri, SE Torrisi… - European …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …
disease, characterised by progressive scarring of the lung and associated with a high …
[HTML][HTML] Current and future treatment landscape for idiopathic pulmonary fibrosis
F Bonella, P Spagnolo, C Ryerson - Drugs, 2023 - Springer
Idiopathic pulmonary fibrosis (IPF) remains a disease with poor survival. The pathogenesis
is complex and encompasses multiple molecular pathways. The first-generation antifibrotics …
is complex and encompasses multiple molecular pathways. The first-generation antifibrotics …
Idiopathic pulmonary fibrosis: new and emerging treatment options
Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating, scarring lung disease
with a worse prognosis than some cancers. The incidence of IPF is increasing and while …
with a worse prognosis than some cancers. The incidence of IPF is increasing and while …
Pharmacological management of idiopathic pulmonary fibrosis: current and emerging options
A Trachalaki, M Irfan, AU Wells - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction Idiopathic Pulmonary Fibrosis is a chronic, progressive lung
disease characterized by worsening lung scarring and the radiological/histological pattern of …
disease characterized by worsening lung scarring and the radiological/histological pattern of …
[HTML][HTML] Recent advances in managing idiopathic pulmonary fibrosis
C Scelfo, A Caminati, S Harari - F1000Research, 2017 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease with a poor prognosis and
severe impact on quality of life. Early diagnosis is still challenging and important delays are …
severe impact on quality of life. Early diagnosis is still challenging and important delays are …